Medicina
Facultad
Vanderbilt University Medical Center
Nashville, Estados UnidosPublicaciones en colaboración con investigadores/as de Vanderbilt University Medical Center (85)
2024
-
Inherited Human BCL10 Deficiencies
Journal of Clinical Immunology, Vol. 44, Núm. 1
2023
-
A meta-analysis of GFR slope as a surrogate endpoint for kidney failure
Nature Medicine, Vol. 29, Núm. 7, pp. 1867-1876
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
A systematic review and meta-analysis of the clinimetric properties of the core outcome measurement instruments for clinical effectiveness trials of nutritional and metabolic interventions in critical illness (CONCISE)
Critical Care, Vol. 27, Núm. 1
-
Change in Albuminuria and GFR Slope as Joint Surrogate End Points for Kidney Failure: Implications for Phase 2 Clinical Trials in CKD
Journal of the American Society of Nephrology : JASN, Vol. 34, Núm. 6, pp. 955-968
-
Evaluation of Variation in the Performance of GFR Slope as a Surrogate End Point for Kidney Failure in Clinical Trials that Differ by Severity of CKD
Clinical journal of the American Society of Nephrology : CJASN, Vol. 18, Núm. 2, pp. 183-192
-
Impact of measurable residual disease on outcomes of unrelated donor haematopoietic cell transplantation with post-transplant cyclophosphamide in AML in first complete remission
British Journal of Haematology, Vol. 201, Núm. 6, pp. 1169-1178
-
Inherited human ezrin deficiency impairs adaptive immunity
Journal of Allergy and Clinical Immunology, Vol. 152, Núm. 4, pp. 997-1009.e11
-
Survival advantage of treosulfan plus fludarabine (FT14) compared to busulfan plus fludarabine (FB4) in active acute myeloid leukemia post allogeneic transplantation: an analysis from the European Society for Blood and Marrow Transplantation (EBMT) Acute Leukemia Working Party (ALWP)
Bone Marrow Transplantation, Vol. 58, Núm. 10, pp. 1084-1088
2022
-
A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function
Kidney International, Vol. 101, Núm. 1, pp. 174-184
-
Acute Treatment Effects on GFR in Randomized Clinical Trials of Kidney Disease Progression
Journal of the American Society of Nephrology : JASN, Vol. 33, Núm. 2, pp. 291-303
-
Adjuvant Palbociclib for Early Breast Cancer: The PALLAS Trial Results (ABCSG-42/AFT-05/BIG-14-03)
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 40, Núm. 3, pp. 282-293
-
Comparison of Outcomes after Unrelated Double-Unit Cord Blood and Haploidentical Peripheral Blood Stem Cell Transplantation in Adults with Acute Myelogenous Leukemia: A Study on Behalf of Eurocord and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Transplantation and Cellular Therapy, Vol. 28, Núm. 10, pp. 710.e1-710.e10
-
Conditional survival and long-term efficacy with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma
Cancer, Vol. 128, Núm. 11, pp. 2085-2097
-
Core outcome measures for clinical effectiveness trials of nutritional and metabolic interventions in critical illness: an international modified Delphi consensus study evaluation (CONCISE)
Critical Care, Vol. 26, Núm. 1
-
Disease Progression of WHIM Syndrome in an International Cohort of 66 Pediatric and Adult Patients
Journal of Clinical Immunology, Vol. 42, Núm. 8, pp. 1748-1765
-
Erratum: Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk (European journal of human genetics : EJHG (2022) 30 3 (349-362))
European journal of human genetics : EJHG
-
First-line Nivolumab plus Ipilimumab Versus Sunitinib in Patients Without Nephrectomy and With an Evaluable Primary Renal Tumor in the CheckMate 214 Trial
European Urology, Vol. 81, Núm. 3, pp. 266-271
-
Mild-to-Moderate Kidney Dysfunction and Cardiovascular Disease: Observational and Mendelian Randomization Analyses
Circulation, Vol. 146, Núm. 20, pp. 1507-1517
-
Polygenic risk modeling for prediction of epithelial ovarian cancer risk
European journal of human genetics : EJHG, Vol. 30, Núm. 3, pp. 349-362